Company / Operating Cash Flow per Share
Candel Therapeutics, Inc. Operating Cash Flow per Share History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.18
FY2023
5-year range
-$1.18 / -$0.77
FY2021-FY2023
Trend
-52.9%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.78 to $-1.18 over the past 2 years.
Based on SEC 10-K filings.
-1.18 in FY2023.
Declined from $-0.78 to $-1.18 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, operating cash flow per share decreased 52.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | -$1.18 | -52.9% |
| FY2022 | -$0.77 | +0.7% |
| FY2021 | -$0.78 | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026